INHIBITEX, INC. 4

4 · INHIBITEX, INC. · Filed Sep 21, 2007

Form 4

Period: 2007-09-19

Vice President

Transactions

Award
Common Stock-Option (Right to Buy)
2007-09-19+27,500→ 27,500 total
Exercise: $3.45Exp: 2017-01-31→ Common Stock (27,500 underlying)
Award
Common Stock
2007-09-19+14,667→ 14,667 total
Award
Common Stock-Option (Right to Buy)
2007-09-19$1.45/sh+140,000$203,000→ 140,000 total
Exercise: $1.45Exp: 2017-09-19→ Common Stock (140,000 underlying)
Award
Common Stock-Option (Right to Buy)
2007-09-19+440,000→ 440,000 total
Exercise: $2.00Exp: 2015-04-04→ Common Stock (440,000 underlying)
Award
Common Stock-Warrant (Right to Buy)
2007-09-19+29,333→ 29,333 total
Exercise: $0.95From: 2007-09-19Exp: 2017-01-10→ Common Stock (29,333 underlying)

Footnotes (7)

[F1]Received in exchange for 26,667 shares of FermaVir Pharmaceuticals, Inc. common stock in connection with the acquisition of FermaVir Pharmaceuticals, Inc. by Inhibitex, Inc. (the "Merger"). Each share of FermaVir common stock was converted into the right to receive 0.55 of a share of Inhibitex common stock.
[F2]Options to purchase 178,750 shares of common stock are vested as of 9/19/2007, options to purchase 123,750 shares of common stock vest on 4/04/2008 and options to purchase 137,500 shares of common stock vest on 4/04/2009.
[F3]Received in the Merger in exchange for common stock options to acquire 800,000 shares of FermaVir common stock.
[F4]Options to purchase 9,167 shares of common stock vest on 1/31/2008 and 1/31/2009 and options to purchase 9,166 shares of common stock vest on 1/31/2010.
[F5]Received in the Merger in exchange for common stock options to acquire 50,000 shares of FermaVir common stock.
[F6]Options to purchase 35,000 shares of common stock vest on 9/19/ 2008, 9/19/2009/ 9/19/2010, and 9/19/2011.
[F7]Received in the Merger in exchange for common stock warrants to acquire 53,333 shares of FermaVir common stock.

Documents

1 file